Assura’s (AGR) Buy Rating Reiterated at Berenberg Bank

Berenberg Bank reaffirmed their buy rating on shares of Assura (LON:AGR) in a research note released on Tuesday morning, Digital Look reports. They currently have a GBX 51 ($0.67) price objective on the real estate investment trust’s stock.

Separately, Shore Capital restated a hold rating on shares of Assura in a research report on Tuesday, August 13th.

Assura Price Performance

Shares of LON:AGR opened at GBX 42.06 ($0.56) on Tuesday. The business’s 50 day simple moving average is GBX 41.60 and its 200-day simple moving average is GBX 41.39. The firm has a market capitalization of £1.36 billion, a price-to-earnings ratio of -4,206.00, a price-to-earnings-growth ratio of 3.60 and a beta of 0.37. The company has a debt-to-equity ratio of 85.04, a current ratio of 0.89 and a quick ratio of 2.84. Assura has a 12 month low of GBX 37.54 ($0.50) and a 12 month high of GBX 49.18 ($0.65).

Assura Announces Dividend

The business also recently disclosed a dividend, which will be paid on Wednesday, October 9th. Investors of record on Thursday, September 5th will be given a dividend of GBX 0.84 ($0.01) per share. The ex-dividend date of this dividend is Thursday, September 5th. This represents a dividend yield of 2.01%. Assura’s dividend payout ratio is currently -30,000.00%.

Insider Buying and Selling at Assura

In other Assura news, insider Jonathan Murphy sold 223,534 shares of the business’s stock in a transaction on Wednesday, July 10th. The stock was sold at an average price of GBX 42 ($0.55), for a total value of £93,884.28 ($124,021.51). 8.38% of the stock is currently owned by insiders.

Assura Company Profile

Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK – caring for more than 600 primary healthcare buildings, from which over six million patients are served. A constituent of the FTSE 250 and the EPRA indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion.